News | April 15, 2015

Zebra Medical Vision Launches Comprehensive Medical Imaging Research Platform

Cloud-based platform provides access to large-scale study datasets along with other research and development tools

April 15, 2015 — Zebra Medical Vision launched a closed beta of its Medical Imaging Research platform and announced funding of $8 million led by Khosla Ventures, with participating parties DeepFork Capital and Salesforce CEO Marc Benioff. The company's solution enables researchers to quickly develop imaging algorithms and insights based on large-scale datasets and advanced processing power. Zebra's commercialization pipeline will then expedite clinical application of imaging research products.

With a billion people joining the middle class by 2020, and an aging global population, the demand for medical imaging is rapidly increasing. Fast, accurate diagnosis is paramount, and is getting increasingly difficult to achieve with existing radiology resources. Medical imaging storage has grown tenfold since 2005 according to a Frost & Sullivan report and continues to grow with more advanced modalities. Therefore there is an acute need for accurate automated tools to enable high-quality diagnostic insights at scale.

"I have frequently commented that technology will reinvent healthcare as we know it," said Vinod Khosla, founder of Khosla Ventures. "Zebra is combining the power of machine learning, computer vision and big data to do just that in medical imaging - creating a sandbox through which imaging innovation can occur and be delivered to patients. We are proud to back such a team and an ambitious endeavor and look forward to seeing the outcomes of the platform."

Zebra's platform offers a cloud-based, fully hosted research and development environment. This includes access to large datasets of structured, de-identified studies, storage, state-of-the-art GPU computing power and support for a multitude of research tools. The platform also enables research groups to collaborate and create joint tools.

"Zebra is the only platform today that offers such seamless access to both the tools and the needed datasets and research environment - and at such a large scale," said Prof. Gabriel Krestinprofessor of radiology, chair of radiology at Erasmus University Medical Centre Rotterdam and past president of the European Society of Radiology. "This will finally enable providers to bring medical imaging into the fold of large scale clinical analysis and population management."

For more information: www.zebra-med.com

Related Content

Although it is likely that existing ultrasound systems will be repurposed to treat COVID-19 patients, growth is still expected as companies plan to ramp up production. The ultrasound systems market will therefore outpace other diagnostic imaging such as computed tomography (CT) and magnetic resonance imaging (MRI). Leading data and analytics company GlobalData forecasts the market will reach $6bn by 2028, but increased usage due to COVID-19 is anticipated have a tangible effect.
News | Ultrasound Imaging | June 05, 2020
June 5, 2020 — Although it is likely that existing...
Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and Drug Administration, discussed The COVID-19 Pandemic — Finding Solutions, Applying Lessons Learned, on June 1

Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and Drug Administration

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — The following speech was delivere
United Imaging's uMR OMEGA is designed to provide greater access to magnetic resonance imaging (MRI) with the world’s first ultra-wide 75-cm bore 3T MRI.
News | Magnetic Resonance Imaging (MRI) | May 27, 2020
May 27, 2020 — United Imaging's...
Off-site imaging companies are playing a key role in the fight against COVID-19
Feature | Coronavirus (COVID-19) | May 26, 2020 | By Sean Zahniser
After the worst of the COVID-19 pandemic has pas
There were several new developments in digital radiography (DR) technology at the 2019 Radiological Society of North America (RSNA) annual meeting. These trends included integration of artificial intelligence (AI) auto detection technologies, more durable glassless detector plates, and technologies to pull more diagnostic data out of X-ray imaging. Some vendors also have redesigned their DR systems to make them more user-friendly and ergonomic. 
Feature | Digital Radiography (DR) | May 26, 2020 | By Dave Fornell
There were several new developments in digital rad...
Lymphocytic Inflammation in a Lung from a Patient Who Died from Covid-19. The gross appearance of a lung from a patient who died from coronavirus disease 2019 (Covid-19) is shown in Panel A (the scale bar corresponds to 1 cm). The histopathological examination, shown in Panel B, revealed interstitial and perivascular predominantly lymphocytic pneumonia with multifocal endothelialitis (hematoxylin–eosin staining; the scale bar corresponds to 200 μm).

Lymphocytic Inflammation in a Lung from a Patient Who Died from Covid-19. The gross appearance of a lung from a patient who died from coronavirus disease 2019 (Covid-19) is shown in Panel A (the scale bar corresponds to 1 cm). The histopathological examination, shown in Panel B, revealed interstitial and perivascular predominantly lymphocytic pneumonia with multifocal endothelialitis (hematoxylin–eosin staining; the scale bar corresponds to 200 μm). Image courtesy of The New England Journal of Medicine

News | Coronavirus (COVID-19) | May 22, 2020
May 22, 2020 — In a new study in the New
Butterfly iQ devices provide revolutionary portable ultrasound capabilities for faster and easier screening and monitoring
News | Coronavirus (COVID-19) | May 20, 2020
May 20, 2020 —Atrium Health is one of the first major health systems in the nation to put into wide practice a new...